0001179110-19-010357.txt : 20190916 0001179110-19-010357.hdr.sgml : 20190916 20190916155852 ACCESSION NUMBER: 0001179110-19-010357 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190905 FILED AS OF DATE: 20190916 DATE AS OF CHANGE: 20190916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prause Burkhard CENTRAL INDEX KEY: 0001544726 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 191094727 MAIL ADDRESS: STREET 1: BRUKER CORPORATION STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2019-09-05 2019-09-09 0 0001109354 BRUKER CORP BRKR 0001544726 Prause Burkhard BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 0 1 0 0 Pres. & CEO, Bruker EST Common Stock 2019-09-05 4 M 0 3718 20.68 A 20758 D Common Stock 2019-09-05 4 M 0 9984 19.82 A 30742 D Common Stock 2019-09-05 4 M 0 2000 22.19 A 32742 D Common Stock 17040 D Stock Option (Right to Buy) 20.68 2019-09-05 4 M 0 3718 0 D 2024-08-08 Common Stock 3718 0 D Stock Option (Right to Buy) 19.82 2019-09-05 4 M 0 9984 0 D 2025-08-07 Common Stock 9984 0 D Stock Option (Right to Buy) 22.19 2019-09-05 4 M 0 2000 0 D 2026-10-04 Common Stock 2000 0 D The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. The option vested in four approximately equal annual installments on August 8, 2015, 2016, 2017 and 2018. The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019. The option vested partially in two annual installments on October 4, 2017 and 2018 with two installments remaining to vest on October 4, 2019 and 2020. /s/ Michael Rich, Attorney-in-Fact 2019-09-16